Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

SMS reminders to help corneal ulcer patients keep follow-up appointments

Official title: Follow-up Compliance for Medically Managed Corneal Ulcer Patients With SMS Reminders in a Tertiary Eye Care Setting in Western Nepal: A Quasi Experimental Study

Run by Seva Canada Society · NCT07377513 · Data updated 2026-11-12

This trial tries using SMS reminders to help adults (18–70) with newly diagnosed corneal ulcers who have a mobile phone keep their scheduled follow-up visits.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment310 (estimated)
SponsorSeva Canada Society
Academic / other
Locations1 site (Siddharthanagar, Lumbini)
StatusRecruiting
StartedFebruary 23, 2026
Main results expectedJune 2027
Study endsDecember 2027
Registry record updatedMay 12, 2026
Trial IDNCT07377513 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–70 years with a newly diagnosed corneal ulcer, managed medically at LEIRC outpatient clinic, who have access to and can receive SMS on a mobile phone.

Probably not a fit

People without access to a mobile phone, those outside the study location, or patients requiring immediate surgical care rather than outpatient medical management are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial enrolls adults aged 18–70 with newly diagnosed corneal ulcers who are medically managed at the outpatient department of Lumbini Eye Institute & Research Center. Participants who own a mobile phone will receive SMS reminders ahead of scheduled follow-up appointments to encourage attendance. The intervention is compared to standard appointment scheduling practices to see if reminders increase follow-up compliance. The rationale is that timely follow-up can reduce complications such as corneal thinning, perforation, and vision loss.

Why it matters

Potential benefit: If successful, SMS reminders could increase follow-up attendance and enable timelier treatment, reducing the risk of complications and vision loss.

How similar studies have gone: Previous ophthalmology programs and mobile health tools (including SMS reminder systems and the Peek Community Eye Health system) have shown improved follow-up rates, though targeted data specifically for corneal ulcer follow-up are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Newly diagnosed patients (18 to 70 years) of corneal ulcer in one or both eye, who are medically managed, visiting the OPD at LEIRC and have access to a mobile phone.

Exclusion Criteria:

* Less than 18 years or more than 70 years Patients who do not have a access to a mobile phone.

Where it's running

  • Lumbini Eye Institute & Research Center
    Siddharthanagar, Lumbini, Nepal
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Intrastromal moxifloxacin added to topical treatment for stubborn bacterial corneal ulcers

    This will test whether injecting moxifloxacin into the cornea, alongside standard moxifloxacin eye drops, helps adults whose bacterial keratitis hasn't improved after 48–72 hours of intensive drops.

    Recruiting Minia University · Minya · NCT07394257

  • Natamycin plus cyclosporine eye drops for fungal corneal ulcers

    This test tries adding cyclosporine eye drops to standard natamycin drops to see if people with fungal corneal ulcers get better vision.

    Recruiting Phase 3 University of California, San Francisco · San Francisco, California and 1 other locations · NCT06658002

  • Using stem cells to treat corneal ulcers

    This study is testing if injections of stem cells from bone marrow can help heal stubborn corneal ulcers and improve vision for people with this condition.

    Recruiting at 2 sites Phase 2 University of Illinois Chicago · Chicago, Illinois and 3 other locations · NCT05705024

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.